559 related articles for article (PubMed ID: 28669838)
1. Antileishmanial and immunomodulatory activities of lupeol, a triterpene compound isolated from Sterculia villosa.
Das A; Jawed JJ; Das MC; Sandhu P; De UC; Dinda B; Akhter Y; Bhattacharjee S
Int J Antimicrob Agents; 2017 Oct; 50(4):512-522. PubMed ID: 28669838
[TBL] [Abstract][Full Text] [Related]
2. Lupeol and amphotericin B mediate synergistic anti-leishmanial immunomodulatory effects in Leishmania donovani-infected BALB/c mice.
Das A; Jawed JJ; Das MC; Parveen S; Ghosh C; Majumdar S; Saha B; Bhattacharjee S
Cytokine; 2021 Jan; 137():155319. PubMed ID: 33002744
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the antileishmanial potency, toxicity and phytochemical constituents of methanol bark extract of Sterculia villosa.
Das A; Das MC; Das N; Bhattacharjee S
Pharm Biol; 2017 Dec; 55(1):998-1009. PubMed ID: 28173714
[TBL] [Abstract][Full Text] [Related]
4. Eugenol derived immunomodulatory molecules against visceral leishmaniasis.
Charan Raja MR; Velappan AB; Chellappan D; Debnath J; Kar Mahapatra S
Eur J Med Chem; 2017 Oct; 139():503-518. PubMed ID: 28826085
[TBL] [Abstract][Full Text] [Related]
5. Related Pentacyclic Triterpenes Have Immunomodulatory Activity in Chronic Experimental Visceral Leishmaniasis.
de Jesus JA; Laurenti MD; Antonangelo L; Faria CS; Lago JHG; Passero LFD
J Immunol Res; 2021; 2021():6671287. PubMed ID: 33681389
[TBL] [Abstract][Full Text] [Related]
6. Lupeol induces immunity and protective efficacy in a murine model against visceral leishmaniasis.
Kaur G; Chauhan K; Kaur S
Parasitology; 2019 Sep; 146(11):1440-1450. PubMed ID: 31104636
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.
Bhattacharya S; Ghosh P; De T; Gomes A; Gomes A; Dungdung SR
Exp Parasitol; 2013 Sep; 135(1):126-33. PubMed ID: 23830987
[TBL] [Abstract][Full Text] [Related]
8. Coccinia grandis (L.) Voigt Leaf Extract Exhibits Antileishmanial Effect Through Pro-inflammatory Response: An In Vitro Study.
Pramanik A; Paik D; Naskar K; Chakraborti T
Curr Microbiol; 2017 Jan; 74(1):59-67. PubMed ID: 27796492
[TBL] [Abstract][Full Text] [Related]
9. Cinnamomum cassia exhibits antileishmanial activity against Leishmania donovani infection in vitro and in vivo.
Afrin F; Chouhan G; Islamuddin M; Want MY; Ozbak HA; Hemeg HA
PLoS Negl Trop Dis; 2019 May; 13(5):e0007227. PubMed ID: 31071090
[TBL] [Abstract][Full Text] [Related]
10. Chromone linked nitrone derivative induces the expression of iNOS2 and Th1 cytokines but reduces the Th2 response in experimental visceral leishmaniasis.
Mallick S; Halder S; Dutta A; Dey S; Paul K; Maiti S; Bandyopadhyay C; Saha B; Pal C
Int Immunopharmacol; 2013 Apr; 15(4):772-9. PubMed ID: 23499679
[TBL] [Abstract][Full Text] [Related]
11. The leishmanicidal activity of oleuropein is selectively regulated through inflammation- and oxidative stress-related genes.
Kyriazis ID; Koutsoni OS; Aligiannis N; Karampetsou K; Skaltsounis AL; Dotsika E
Parasit Vectors; 2016 Aug; 9(1):441. PubMed ID: 27501956
[TBL] [Abstract][Full Text] [Related]
12. Asiaticoside induces tumour-necrosis-factor-α-mediated nitric oxide production to cure experimental visceral leishmaniasis caused by antimony-susceptible and -resistant Leishmania donovani strains.
Bhaumik SK; Paul J; Naskar K; Karmakar S; De T
J Antimicrob Chemother; 2012 Apr; 67(4):910-20. PubMed ID: 22258930
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral Leishmaniasis.
Islamuddin M; Chouhan G; Want MY; Ozbak HA; Hemeg HA; Afrin F
PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005011. PubMed ID: 27776125
[TBL] [Abstract][Full Text] [Related]
14. Activity of a novel sulfonamide compound 2-nitro-N-(pyridin-2-ylmethyl)benzenesulfonamide against Leishmania donovani.
Dikhit MR; Purkait B; Singh R; Sahoo BR; Kumar A; Kar RK; Ansari MY; Saini S; Abhishek K; Sahoo GC; Das S; Das P
Drug Des Devel Ther; 2016; 10():1753-61. PubMed ID: 27307706
[TBL] [Abstract][Full Text] [Related]
15. Curative efficacy of purified serine protease inhibitor PTF3 from potato tuber in experimental visceral leishmaniasis.
Paik D; Pramanik PK; Chakraborti T
Int Immunopharmacol; 2020 Aug; 85():106623. PubMed ID: 32504996
[TBL] [Abstract][Full Text] [Related]
16. Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani.
Kaur J; Sundar S; Singh N
J Antimicrob Chemother; 2010 Aug; 65(8):1742-8. PubMed ID: 20519355
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of antileishmanial efficacy of Salidroside against the SSG-sensitive and resistant strain of Leishmania donovani.
Chauhan K; Kaur G; Kaur S
Parasitol Int; 2019 Oct; 72():101928. PubMed ID: 31108221
[TBL] [Abstract][Full Text] [Related]
18. 18 Beta-glycyrrhetinic acid triggers curative Th1 response and nitric oxide up-regulation in experimental visceral leishmaniasis associated with the activation of NF-kappa B.
Ukil A; Biswas A; Das T; Das PK
J Immunol; 2005 Jul; 175(2):1161-9. PubMed ID: 16002718
[TBL] [Abstract][Full Text] [Related]
19. Nitroimidazo-oxazole compound DNDI-VL-2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis.
Gupta S; Yardley V; Vishwakarma P; Shivahare R; Sharma B; Launay D; Martin D; Puri SK
J Antimicrob Chemother; 2015 Feb; 70(2):518-27. PubMed ID: 25389223
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Potential of Quercetin-Loaded Nanoemulsion against Experimental Visceral Leishmaniasis:
Das SS; Dubey AK; Verma PRP; Singh SK; Singh SK
Mol Pharm; 2022 Sep; 19(9):3367-3384. PubMed ID: 35980291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
